Five9 to Report Third Quarter 2023 Financial Results on November 2, 2023
Five9, Inc. (Nasdaq: FIVN), the Intelligent CX Platform provider, today provided details for its third quarter 2023 financial results conference call on Thursday, November 2, 2023, at 4:30 p.m. Eastern Time.
Participants may register for the Zoom Video webinar at 4:30 p.m. Eastern Time on November 2, 2023, by clicking here. A replay will be available shortly after the conclusion of the live event and will remain up for approximately one week.
Both the live webcast and replay will be available on the Investor Relations section of the Company's website at http://investors.five9.com/.
About Five9
The Five9 Intelligent CX Platform provides a comprehensive suite of solutions for orchestrating fluid customer experiences. Our cloud-native, multi-tenant, scalable, reliable and secure platform includes contact center; omni-channel engagement; Workforce Engagement Management; extensibility through more than 1,000 partners; and innovative, practical AI, automation and journey analytics that are embedded as part of the platform. Five9 brings the power of people, technology and partners to more than 2,500 organizations worldwide.
On June 29, the "Gather Great Wisdom to Shape the Future of Intelligent Manufacturing?Special Exhibition on Design Intelligence and High Quality Development", hosted by the China Academy of Art (CAA), opened at the National Museum of China in...
Intermap Technologies ("Intermap" or the "Company"), a global leader in 3D geospatial products and intelligence solutions, announces a new financing. The Company is offering up to a maximum of 4,300,000 Class "A" common shares of the Company...
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...
Enterprises in Asia Pacific are moving toward software-defined networking (SDN) to make communication more secure and resilient and speed up business decision-making, according to a new research report published today by Information Services Group...
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal...
